Fingerprint
Dive into the research topics of 'Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
S. A. Long, M. Rieck, S. Sanda, J. B. Bollyky, P. L. Samuels, R. Goland, A. Ahmann, A. Rabinovitch, S. Aggarwal, D. Phippard, L. A. Turka, M. R. Ehlers, P. J. Bianchine, K. D. Boyle, S. A. Adah, J. A. Bluestone, J. H. Buckner, C. J. Greenbaum
Research output: Contribution to journal › Comment/debate › peer-review